NCT04239950View on ClinicalTrials.gov

Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

PHASE3CompletedINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

May 9, 2020

Primary Completion Date

July 20, 2023

Study Completion Date

July 20, 2023

Conditions
Hypertriglyceridemia
Interventions
DRUG

Placebo

Placebo

DRUG

Ethyl Icosapentate

Ethyl Icosapentate

Trial Locations (1)

Unknown

Mochida Investigational sites, Changsha

Sponsors
All Listed Sponsors
collaborator

Sumitomo Pharma (Suzhou) Co., Ltd.

INDUSTRY

lead

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

NCT04239950 - Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia | Biotech Hunter | Biotech Hunter